Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
Transl Psychiatry ; 10(1): 343, 2020 10 09.
Article in English | MEDLINE | ID: mdl-33037178

ABSTRACT

The transcription factor TCF4 was confirmed in several large genome-wide association studies as one of the most significant schizophrenia (SZ) susceptibility genes. Transgenic mice moderately overexpressing Tcf4 in forebrain (Tcf4tg) display deficits in fear memory and sensorimotor gating. As second hit, we exposed Tcf4tg animals to isolation rearing (IR), chronic social defeat (SD), enriched environment (EE), or handling control (HC) conditions and examined mice with heterozygous deletion of the exon 4 (Tcf4Ex4δ+/-) to unravel gene-dosage effects. We applied multivariate statistics for behavioral profiling and demonstrate that IR and SD cause strong cognitive deficits of Tcf4tg mice, whereas EE masked the genetic vulnerability. We observed enhanced long-term depression in Tcf4tg mice and enhanced long-term potentiation in Tcf4Ex4δ+/- mice indicating specific gene-dosage effects. Tcf4tg mice showed higher density of immature spines during development as assessed by STED nanoscopy and proteomic analyses of synaptosomes revealed concurrently increased levels of proteins involved in synaptic function and metabolic pathways. We conclude that environmental stress and Tcf4 misexpression precipitate cognitive deficits in 2-hit mouse models of relevance for schizophrenia.


Subject(s)
Schizophrenia , Animals , Cognition , Disease Models, Animal , Genome-Wide Association Study , Mice , Mice, Transgenic , Neuronal Plasticity/genetics , Proteomics , Schizophrenia/genetics
2.
Transl Psychiatry ; 7(6): e1159, 2017 06 27.
Article in English | MEDLINE | ID: mdl-28654095

ABSTRACT

Preliminary studies suggest that, besides improving cognition, aerobic exercise might increase hippocampal volume in schizophrenia patients; however, results are not consistent. Individual mechanisms of volume changes are unknown but might be connected to the load of risk genes. Genome-wide association studies have uncovered the polygenic architecture of schizophrenia. The secondary analysis presented here aimed to determine the modulatory role of schizophrenia polygenic risk scores (PRSs) on volume changes in the total hippocampus and cornu ammonis (CA) 1, CA2/3, CA4/dentate gyrus (DG) and subiculum over time. We studied 20 multi-episode schizophrenia patients and 23 healthy controls who performed aerobic exercise (endurance training) combined with cognitive remediation for 3 months and 21 multi-episode schizophrenia patients allocated to a control intervention (table soccer) combined with cognitive remediation. Magnetic resonance imaging-based assessments were performed at baseline and after 3 months with FreeSurfer. No effects of PRSs were found on total hippocampal volume change. Subfield analyses showed that the volume changes between baseline and 3 months in the left CA4/DG were significantly influenced by PRSs in schizophrenia patients performing aerobic exercise. A larger genetic risk burden was associated with a less pronounced volume increase or a decrease in volume over the course of the exercise intervention. Results of exploratory enrichment analyses reinforced the notion of genetic risk factors modulating biological processes tightly related to synaptic ion channel activity, calcium signaling, glutamate signaling and regulation of cell morphogenesis. We hypothesize that a high polygenic risk may negatively influence neuroplasticity in CA4/DG during aerobic exercise in schizophrenia.


Subject(s)
Cognitive Remediation , Exercise Therapy , Hippocampus/physiopathology , Multifactorial Inheritance , Neuronal Plasticity , Schizophrenia/genetics , Schizophrenia/therapy , Exercise , Genetic Predisposition to Disease , Hippocampus/pathology , Humans , Magnetic Resonance Imaging , Schizophrenia/physiopathology , Treatment Outcome
3.
Eur Arch Psychiatry Clin Neurosci ; 266(6): 505-12, 2016 Sep.
Article in English | MEDLINE | ID: mdl-26404636

ABSTRACT

Schizophrenia (SZ) is a severe mental disorder affecting about 1 % of the human population. Patients show severe deficits in cognitive processing often characterized by an improper filtering of environmental stimuli. Independent genome-wide association studies confirmed a number of risk variants for SZ including several associated with the gene encoding the transcription factor 4 (TCF4). TCF4 is widely expressed in the central nervous system of mice and humans and seems to be important for brain development. Transgenic mice overexpressing murine Tcf4 (Tcf4tg) in the adult brain display cognitive impairments and sensorimotor gating disturbances. To address the question of whether increased Tcf4 gene dosage may affect cognitive flexibility in an auditory associative task, we tested latent inhibition (LI) in female Tcf4tg mice. LI is a widely accepted translational endophenotype of SZ and results from a maladaptive delay in switching a response to a previously unconditioned stimulus when this becomes conditioned. Using an Audiobox, we pre-exposed Tcf4tg mice and their wild-type littermates to either a 3- or a 12-kHz tone before conditioning them to a 12-kHz tone. Tcf4tg animals pre-exposed to a 12-kHz tone showed significantly delayed conditioning when the previously unconditioned tone became associated with an air puff. These results support findings that associate TCF4 dysfunction with cognitive inflexibility and improper filtering of sensory stimuli observed in SZ patients.


Subject(s)
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics , Cognition Disorders/genetics , General Adaptation Syndrome/genetics , Sensory Gating/genetics , Acoustic Stimulation , Animals , Disease Models, Animal , Exploratory Behavior/physiology , Female , Inhibition, Psychological , Locomotion/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Psychoacoustics , Transcription Factor 4
4.
Neuroscience ; 314: 1-11, 2016 Feb 09.
Article in English | MEDLINE | ID: mdl-26628400

ABSTRACT

Chronic psychosocial stress is an important environmental risk factor for the development of psychiatric diseases. However, studying the impact of chronic psychosocial stress in mice is time consuming and thus not optimally suited to 'screen' increasing numbers of genetically manipulated mouse models for psychiatric endophenotypes. Moreover, many studies focus on restraint stress, a strong physical stressor with limited relevance for psychiatric disorders. Here, we describe a simple and a rapid method based on the resident-intruder paradigm to examine acute effects of mild psychosocial stress in mice. The OSO paradigm (open field--social defeat--open field) compares behavioral consequences on locomotor activity, anxiety and curiosity before and after exposure to acute social defeat stress. We first evaluated OSO in male C57Bl/6 wildtype mice where a single episode of social defeat reduced locomotor activity, increased anxiety and diminished exploratory behavior. Subsequently, we applied the OSO paradigm to mouse models of two schizophrenia (SZ) risk genes. Transgenic mice with neuronal overexpression of Neuregulin-1 (Nrg1) type III showed increased risk-taking behavior after acute stress exposure suggesting that NRG1 dysfunction is associated with altered affective behavior. In contrast, Tcf4 transgenic mice displayed a normal stress response which is in line with the postulated predominant contribution of TCF4 to cognitive deficits of SZ. In conclusion, the OSO paradigm allows for rapid screening of selected psychosocial stress-induced behavioral endophenotypes in mouse models of psychiatric diseases.


Subject(s)
Behavior, Animal , Disease Models, Animal , Mice/physiology , Schizophrenic Psychology , Stress, Psychological , Animals , Anxiety , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics , Endophenotypes , Exploratory Behavior , Male , Mice, Inbred C57BL , Mice, Transgenic , Motor Activity , Neuregulin-1/genetics , Schizophrenia/genetics , Social Behavior , Social Environment , Transcription Factor 4
5.
Mol Psychiatry ; 20(6): 671-6, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25824303

ABSTRACT

One hundred years after its conceptual definition as 'Dementia Praecox' by Emil Kraepelin, schizophrenia is still a serious psychiatric illness that affects young adults and leads to disability in at least half of patients. The key treatment issue is partial or non-response, especially of negative symptoms. The illness is also associated with different degrees of cognitive dysfunction, particularly in verbal and working memory; the resulting functional impairment may lead to unemployment and an inability to maintain stable relationships. Patients' cognitive dysfunction led Kraepelin to the assumption that schizophrenia is a form of juvenile dementia caused by a degenerative process of the human brain. Postmortem studies and a plethora of imaging studies do not support the notion of a degenerative process, but such a process is supported by the recently published, largest genome-wide association study on schizophrenia. More than a 100 hits were described, converging on pathways that have a significant role in dopamine metabolism in immune modulation, calcium signalling and synaptic plasticity. This review suggests that research should focus on animal models based on risk genes like transcription factor 4 and study the effects of exposure to environmental stressors relevant for schizophrenia. The use of relevant end points like pre-pulse inhibition or cognitive dysfunction will allow us to gain an understanding of the molecular pathways in schizophrenia and consequently result in improved treatment options, especially for the disabling aspects of this illness.


Subject(s)
Cognition Disorders/etiology , Nerve Degeneration/etiology , Regeneration/physiology , Schizophrenia/complications , Schizophrenia/history , Animals , History, 19th Century , History, 20th Century , History, 21st Century , Humans
6.
J Neurosci ; 18(4): 1408-18, 1998 Feb 15.
Article in English | MEDLINE | ID: mdl-9454850

ABSTRACT

Basic helix-loop-helix (bHLH) genes have emerged as important regulators of neuronal determination and differentiation in vertebrates. Three putative neuronal differentiation factors [NEX for neuronal helix-loop-helix protein-1 (mammalian atonal homolog-2), neuroD (beta-2), and NDRF for neuroD-related factor (neuroD2)] are highly homologous to each other in the bHLH region and comprise a new bHLH subfamily. To study the role of NEX, the first bHLH protein identified in this group, we have disrupted the NEX gene by homologous recombination. NEX-deficient mice have no obvious developmental defect, and CNS neurons appear fully differentiated. To investigate further whether the absence of NEX is compensated for by neuroD and NDRF, we compared the spatiotemporal expression of all three genes. We demonstrate, by in situ hybridization, that the transcription patterns of NEX, neuroD, and NDRF genes are highly overlapping in the developing CNS of normal rats between embryonic day 12 and adult stages but are not strictly identical. The most prominent transcription of each gene marks the dorsal neuroepithelium of the telencephalon in early development and is sustained in the adult neocortex, hippocampus, and cerebellum. In general, neuroD provides the earliest marker of neuronal differentiation in any given region compared with NDRF or NEX. Whereas a few CNS regions are specific for neuroD, no region was detected in which solely NEX or NDRF is expressed. This suggests that the function of the mutant NEX gene in neuronal differentiation is compensated for by neuroD and NDRF and that, in analogy with myogenic bHLH proteins, neuronal differentiation factors are at least in part equivalent in function.


Subject(s)
Mice, Transgenic/genetics , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Neuropeptides/metabolism , Aging/metabolism , Animals , Animals, Newborn/growth & development , Animals, Newborn/metabolism , Basic Helix-Loop-Helix Transcription Factors , Brain/metabolism , Cell Differentiation/physiology , Embryonic and Fetal Development/physiology , Gene Expression/physiology , Helix-Loop-Helix Motifs/genetics , Mice , Neurons/cytology , Neuropeptides/genetics , Rats , Rats, Sprague-Dawley
7.
Mol Cell Neurosci ; 9(5-6): 460-75, 1997.
Article in English | MEDLINE | ID: mdl-9361282

ABSTRACT

In the mammalian central nervous system, a diverse group of basic helix-loop-helix (bHLH) proteins is involved in the determination of progenitor cells and, subsequently, in regulating neuronal differentiation. Here we report the identification of a novel subfamily of bHLH proteins, defined by two mammalian enhancer-of-split- and hairy-related proteins, termed SHARP-1 and SHARP-2. In contrast to known bHLH genes, detectable transcription of SHARP genes begins at the end of embryonic development marking differentiated neurons that have reached a final position, and increases as postnatal development proceeds. In the adult, SHARP genes are expressed in subregions of the CNS that have been associated with adult plasticity. In PC12 cells, a model system to study neurite outgrowth, SHARP genes can be induced by NGF with the kinetics of an immediate-early gene. Similarly, within 1 h after the administration of kainic acid in vivo, SHARP-2 is induced in neurons throughout the rat cerebral cortex. This suggests that neuronal bHLH proteins are also involved in the "adaptive" changes of mature CNS neurons which are coupled to glutamatergic stimulation.


Subject(s)
Drosophila Proteins , Helix-Loop-Helix Motifs/physiology , Homeodomain Proteins , Neurons/physiology , Neuropeptides/physiology , Transcription Factors/physiology , Amino Acid Sequence , Animals , Animals, Newborn , Basic Helix-Loop-Helix Transcription Factors , DNA-Binding Proteins/physiology , Embryo, Mammalian , Gene Expression Regulation, Developmental/drug effects , Helix-Loop-Helix Motifs/genetics , Insect Proteins/physiology , Kainic Acid/pharmacology , Male , Molecular Sequence Data , Multigene Family , Nerve Growth Factors/pharmacology , Neuropeptides/biosynthesis , Neuropeptides/genetics , PC12 Cells , Rats , Rats, Sprague-Dawley , Repressor Proteins/physiology , Transcription Factors/biosynthesis , Transcription Factors/genetics
8.
Mol Cell Neurosci ; 10(3-4): 460-75, 1997.
Article in English | MEDLINE | ID: mdl-9532582

ABSTRACT

In the mammalian central nervous system, a diverse group of basic helix-loop-helix (bHLH) proteins is involved in the determination of progenitor cells and, subsequently, in regulating neuronal differentiation. Here we report the identification of a novel subfamily of bHLH proteins, defined by two mammalian enhancer-of-split- and hairy-related proteins, termed SHARP-1 and SHARP-2. In contrast to known bHLH genes, detectable transcription of SHARP genes begins at the end of embryonic development marking differentiated neurons that have reached a final position, and increases as postnatal development proceeds. In the adult, SHARP genes are expressed in subregions of the CNS that have been associated with adult plasticity. In PC12 cells, a model system to study neurite outgrowth, SHARP genes can be induced by NGF with the kinetics of an immediate-early gene. Similarly, within 1 h after the administration of kalnic acid in vivo, SHARP-2 is induced in neurons throughout the rat cerebral cortex. This suggests that neuronal bHLH proteins are also involved in the "adaptive" changes of mature CNS neurons which are coupled to glutamatergic stimulation.


Subject(s)
Homeodomain Proteins , Neurons/physiology , Neuropeptides/physiology , Transcription Factors/physiology , Amino Acid Sequence , Animals , Basic Helix-Loop-Helix Transcription Factors , Brain/metabolism , Gene Expression Regulation/drug effects , Helix-Loop-Helix Motifs/genetics , Humans , Kainic Acid/pharmacology , Mice , Molecular Sequence Data , Multigene Family , Nerve Growth Factors/pharmacology , Neurons/metabolism , Neuropeptides/biosynthesis , Neuropeptides/genetics , Organ Specificity/genetics , PC12 Cells , Rats , Rats, Sprague-Dawley , Sequence Homology, Amino Acid , Transcription Factors/biosynthesis , Transcription Factors/genetics
9.
Neuron ; 16(5): 1049-60, 1996 May.
Article in English | MEDLINE | ID: mdl-8630243

ABSTRACT

Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy in humans and has been associated with a partial duplication of chromosome 17 (CMT type 1A). We have generated a transgenic rat model of this disease and provide experimental evidence that CMT1A is caused by increased expression of the gene for peripheral myelin protein-22 (PMP22, gas-3). PMP22-transgenic rats develop gait abnormalities caused by a peripheral hypomyelination, Schwann cell hypertrophy (onion bulb formation), and muscle weakness. Reduced nerve conduction velocities closely resemble recordings in human patients with CMT1A. When bred to homozygosity, transgenic animals completely fail to elaborate myelin. We anticipate that the CMT rat model will facilitate the identification of a cellular disease mechanism and serve in the evaluation of potential treatment strategies.


Subject(s)
Charcot-Marie-Tooth Disease/genetics , Myelin Proteins/genetics , Animals , Animals, Genetically Modified , Base Sequence , DNA Primers/chemistry , Demyelinating Diseases/genetics , Disease Models, Animal , Gene Expression , Homozygote , Humans , Molecular Sequence Data , Neural Conduction , Rats , Schwann Cells/cytology
SELECTION OF CITATIONS
SEARCH DETAIL